Molecular methods, such as phylogenomics, can be used to accurately track pathogens. Valik et al. incorporate genomic biomarkers from Pseudomonas aeruginosa isolates and clinical data into machine ...

Heterogeneity is ubiquitous in real-world host populations, yet most theories assume homogeneity. Using a metapopulation model, we examine how host heterogeneities, such as uneven movement patterns ...

The evolution of pathogens has received attention in a wide range of scientific fields, such as epidemiology, demography, and ...

Since the COVID-19 pandemic, considerable advances have been made to improve epidemic preparedness by accelerating ...

Heterogeneity in host populations significantly influences pathogen evolution, yet most theories assume uniformity. This ...

Earlier this year, Russian President Vladimir Putin had said that the scientists in the country were close to creating ...

In her opening speech, HE Dr. Amna bint Abdullah Al Dahak emphasised the importance of joint cooperation and coordinated ...

Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor ...

Earlier, confirmation on the cancer vaccine's pre-trial came from Alexander Gintsburg, Director of the Gamaleya National Research Center for Epidemiology and Microbiology ... should look like uses ...

Russia this week claimed it has developed its own mRNA-based vaccine to treat cancer, which will be available for free to patients from early 2025.

This revolutionary vaccine, set to be launched in early 2025, will be distributed free of cost to Russian citizens ...

Russia has developed an mRNA cancer vaccine and plans to release it publicly in early 2025, free of charge. Pre-clinical trials show it inhibits tumor growth and spread. Researchers are also using AI ...